News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Middle East conflict extends, lifting oil prices and disrupting Strait of Hormuz maritime traffic.
  • Asian currencies slide and global bond volatility rises as investors price the conflict risk.
  • UBS pushes expected Fed rate cuts to December 2026, citing firmer inflation and jobs data.
  • India mobilizes FX reserves, import curbs and regulatory tools after $20 billion portfolio outflows and rising import costs.
  • Shanghai stocks hit an 11-year peak as Nvidia CEO's presence boosts China tech ahead of the U.S.-China summit.
  • Birkenstock shares plunge over 11% after Q2 revenue and profit missed estimates and a conflict-related EMEA charge.

Latest Articles

Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026

Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026

Achieve Life Sciences, a specialty pharmaceutical company focused on cytisinicline for nicotine dependence treatment, announced it will release its Q1 2026 financial results and hold a conference call on May 12, 2026. The announcement comes as the FDA is reviewing its New Drug Application with a PDUFA date set for June 20, 2026, potentially approvi…

Eagle Nuclear Energy Announces Commencement of Environmental Baseline Studies in Advance of PFS-Related Drill Program at Aurora

Eagle Nuclear Energy Announces Commencement of Environmental Baseline Studies in Advance of PFS-Related Drill Program at Aurora

Eagle Nuclear Energy Corp. has initiated comprehensive environmental baseline studies prior to a 27,000 ft Pre-Feasibility Study drilling program at its Aurora Uranium Project located on the Oregon-Nevada border. These studies cover hydrology, geochemistry, flora and fauna, wetlands, meteorology, and cultural heritage to facilitate environmental im…

Forward Industries and RockawayX Co-Lead Strategic Investment in OnRe to Accelerate Onchain Reinsurance on Solana

Forward Industries and RockawayX Co-Lead Strategic Investment in OnRe to Accelerate Onchain Reinsurance on Solana

Forward Industries announced a strategic co-led $5 million Series A investment in OnRe, a Bermuda-licensed onchain reinsurance firm on Solana, alongside RockawayX. Forward intends to deploy up to $25 million into OnRe's token ONyc, which offers yield from reinsurance risk through blockchain integration. This aligns with Forward's strategy to divers…

Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value

Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value

Profusa, Inc. has announced a board-led process to evaluate strategic growth alternatives, including partnerships, mergers, or asset transactions, aiming to enhance scale and shareholder value. Concurrently, the company is focusing resources on advancing the Lumee Oxygen platform toward European CE Mark certification and expanding revenue through i…

Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis

Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis

Palisade Bio announced additional Phase 1a/b data for PALI-2108, a once-daily oral PDE4 inhibitor prodrug selectively activated in the ileum and colon, demonstrating sustained target engagement above IC90, colon-selective pathway modulation, and strong clinical, histologic, and biomarker improvements in ulcerative colitis patients. This supports co…

Foremost Clean Energy Advances CLK Uranium Property With Results of MobileMT and Ambient Noise Tomography Surveys Following up Historic High-Grade Showing

Foremost Clean Energy Advances CLK Uranium Property With Results of MobileMT and Ambient Noise Tomography Surveys Following up Historic High-Grade Showing

Foremost Clean Energy Ltd. announced results from its 2025 helicopter-borne MobileMT electromagnetic survey and ambient noise tomography survey at its CLK Uranium Property in Saskatchewan's Athabasca Basin. The surveys identified complex conductive anomalies and structural features associated with high-grade uranium mineralization, supporting refin…

Chanson International Holding Announces 100 for 1 Share Consolidation

Chanson International Holding Announces 100 for 1 Share Consolidation

Chanson International Holding, a China and US-based bakery and beverage products provider listed on Nasdaq under the ticker CHSN, announced a 100-for-1 share consolidation effective May 7, 2026. The consolidation will reduce the total shares outstanding, increase the par value per share, and maintain the current trading symbol under a new CUSIP. Th…

IMUNON to Hold First Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, May 12, 2026

IMUNON to Hold First Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, May 12, 2026

IMUNON, Inc., a clinical-stage biotech developing DNA-mediated immunotherapies, announced its Q1 2026 financial results and business update conference call set for May 12, 2026. The company will provide updates on IMNN-001, its lead DNA-based interleukin-12 immunotherapy in Phase 3 trials for advanced ovarian cancer, and report progress on its clin…

BGIN BLOCKCHAIN LIMITED Reveals PortableBTC at Bitcoin 2026

BGIN BLOCKCHAIN LIMITED Reveals PortableBTC at Bitcoin 2026

BGIN BLOCKCHAIN LIMITED revealed its PortableBTC commemorative prototype miner at the Bitcoin 2026 conference, signaling the company's move into Bitcoin mining hardware development and consumer-oriented mining products under its "Crypto for All" vision. The prototype, powered by the company's BT1 ASIC chip, represents a milestone in BGIN's ASIC des…

SAB BIO to Host First Quarter 2026 Financial Results Conference Call and Webcast on May 12, 2026, 08:30 AM ET

SAB BIO to Host First Quarter 2026 Financial Results Conference Call and Webcast on May 12, 2026, 08:30 AM ET

SAB Biotherapeutics, Inc. will release its first quarter 2026 financial results on May 12, 2026, followed by a conference call and webcast at 8:30 AM ET to discuss the results and provide business updates. The company is a clinical-stage biopharmaceutical firm focused on developing fully human immunoglobulin therapeutics for autoimmune diseases, wi…

FibroBiologics CEO Issues Letter to Shareholders

FibroBiologics CEO Issues Letter to Shareholders

FibroBiologics, Inc., a clinical-stage biotechnology company, announced the initiation of its clinical trial for CYWC628, an investigational fibroblast-based therapy aimed at treating diabetic foot ulcers (DFUs). The company highlighted the importance of this milestone as it transitions from development to clinical execution. It plans to begin pati…

Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites

Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites

Microbot Medical Inc. announced strong commercial adoption of its LIBERTY Endovascular Robotic System, including by sites involved in the ACCESS-PVI pivotal clinical trial. The company is experiencing increased interest following its full market release and is expanding its global presence, highlighted by participation in the upcoming GEST Conferen…

Fate Therapeutics Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of FT819

Fate Therapeutics Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of FT819

Fate Therapeutics announced FT819, its off-the-shelf CAR T-cell therapy candidate for moderate-to-severe systemic lupus erythematosus (SLE), has been selected for the FDA's Chemistry, Manufacturing, and Controls Development and Readiness Pilot (CDRP) Program. Coupled with the existing Regenerative Medicine Advanced Therapy (RMAT) designation, this …

TRUGOLF LINKS REGIONAL DEVELOPER SIGNS LEASE FOR SECOND LOCATION

TRUGOLF LINKS REGIONAL DEVELOPER SIGNS LEASE FOR SECOND LOCATION

TruGolf, a Nasdaq-listed company specializing in high-tech golf simulators, has signed a lease for a second flagship TruGolf Links Center location in Farmingdale, New York. This new 6,120 square foot facility will offer premium indoor golf simulators, an upscale restaurant with a full bar, and a multi-sport arcade, aiming to deliver an enhanced 'ea…

Abbas’s Son Seeks Party Role as Succession Tensions Rise in Palestinian Leadership

Abbas’s Son Seeks Party Role as Succession Tensions Rise in Palestinian Leadership

Yasser Abbas, a wealthy businessman and son of President Mahmoud Abbas, is reported to be seeking a seat on Fatah’s Central Committee during a long-delayed party conference in Ramallah. His potential elevation has intensified a succession struggle over control of the Palestinian Authority and the PLO, drawing criticism from within Fatah and raising…